Artykuły w czasopismach na temat „Min yong fei ji”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 25 najlepszych artykułów w czasopismach naukowych na temat „Min yong fei ji”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Greco, Venanzio R. "Discussion of “Effects of Strain Localization on Seismic Active Earth Pressures” by Jian-Min Zhang, Fei Song, and De-Ji Li". Journal of Geotechnical and Geoenvironmental Engineering 137, nr 12 (grudzień 2011): 1316. http://dx.doi.org/10.1061/(asce)gt.1943-5606.0000493.
Pełny tekst źródłaZhang, Jian-Min, Fei Song i De-Ji Li. "Closure to “Effects of Strain Localization on Seismic Active Earth Pressures” by Jian-Min Zhang, Fei Song, and De-Ji Li". Journal of Geotechnical and Geoenvironmental Engineering 137, nr 12 (grudzień 2011): 1316–17. http://dx.doi.org/10.1061/(asce)gt.1943-5606.0000594.
Pełny tekst źródłaKim, Joseph, Jai-Hee Moon, Kyung-Mi Lee, Hyun Ryu, Eun Hye Park, Sang Hee Kim, Jeong Seok Kim i in. "Abstract 6219: WM-S1, the novel small molecule inhibitor of mutant RTK/receptor tyrosine kinase, for the treatment of cancer". Cancer Research 82, nr 12_Supplement (15.06.2022): 6219. http://dx.doi.org/10.1158/1538-7445.am2022-6219.
Pełny tekst źródłaB., Ariunbaigali. "“Гуулин улсын судар”-ын тухай". Mongolian Journal of Foreign Languages and Culture 20, nr 450 (2.03.2023): 15–26. http://dx.doi.org/10.22353/mjflc.v20i450.2852.
Pełny tekst źródłaPark, Minsu, Tae-Min Cho, Soeun Park, Jung Min Park, Juyeon Seo, Dongmi Ko, Seongjae Kim i in. "Abstract 3712: The C-terminal HSP90 inhibitor, a novel deguelin derivative, exerts anti-metastatic effects in triple-negative breast cancer by targeting cancer stem-like properties". Cancer Research 82, nr 12_Supplement (15.06.2022): 3712. http://dx.doi.org/10.1158/1538-7445.am2022-3712.
Pełny tekst źródłaHoang, Tung, Min Jung Kim, Ji Won Park, Seung-Yong Jeong, Jeeyoo Lee i Aesun Shin. "Abstract 3062: Modifiable factors and gut microbiome alteration among colorectal cancer patients". Cancer Research 82, nr 12_Supplement (15.06.2022): 3062. http://dx.doi.org/10.1158/1538-7445.am2022-3062.
Pełny tekst źródłaRyu, Won-Ji, Shinyoung Park, Jeong Dong Lee, Yumi Hwang, Seongyeon Jo, Kweon Tae Yong, Ja Seung Koo, Min Hwan Kim, Joo Hyuk Sohn i Hyung Seok Park. "Abstract 178: Establishment of patient-derived organoid of breast cancer". Cancer Research 83, nr 7_Supplement (4.04.2023): 178. http://dx.doi.org/10.1158/1538-7445.am2023-178.
Pełny tekst źródłaJung, Eunsun, Seojin Jang, Daeil Sung, Soeun Park, Minsu Park, Dongmi Ko, Seongjae Kim i in. "Abstract 4911: A novel C-terminal of HSP90 inhibitor NCT-547 eliminates cancer stem-like subpopulation in triple-negative breast cancer". Cancer Research 83, nr 7_Supplement (4.04.2023): 4911. http://dx.doi.org/10.1158/1538-7445.am2023-4911.
Pełny tekst źródłaJun, So Yon, Sooyoung Cho, Min Jung Kim, Ji Won Park, Seung Yong Jeong i Aesun Shin. "Abstract 7319: Glycemic traits and colorectal cancer survival in a cohort of South Korean patients: A Mendelian randomization analysis". Cancer Research 84, nr 6_Supplement (22.03.2024): 7319. http://dx.doi.org/10.1158/1538-7445.am2024-7319.
Pełny tekst źródłaLee, Han-Byoel, Ji Gwang Jung, Jung Min Chang, Ji Hyun Chang, Woo Kyung Moon, Kyung Hwan Shin, Il Yong Chung i in. "Abstract OT1-04-02: The NAUTILUS trial (No Axillary sUrgical Treatment In clinically Lymph node negative patients after UltraSonography): A prospective multicenter randomized phase III trial (NCT04303715)". Cancer Research 82, nr 4_Supplement (15.02.2022): OT1–04–02—OT1–04–02. http://dx.doi.org/10.1158/1538-7445.sabcs21-ot1-04-02.
Pełny tekst źródłaKan, Zhengyan, Seock-Ah Im, Kyunghee Park, Ji Wen, Kyung-Hun Lee, Yoon-La Choi, Won-Chul Lee i in. "Abstract PD2-08: Serial genomic profiling reveals molecular mechanisms of breast cancer resistance to palbociclib". Cancer Research 82, nr 4_Supplement (15.02.2022): PD2–08—PD2–08. http://dx.doi.org/10.1158/1538-7445.sabcs21-pd2-08.
Pełny tekst źródłaCheng, Minyi, Liulu Zhang, Yuanqi Chen, Xiaosheng Zhuang, Ciqiu Yang, Fei Ji, Hongfei Gao, Mei Yang, Teng Zhu i Jieqing Li. "Abstract P1-01-03: Feasibility and diagnostic performance of ultrasound assisted carbon nanoparticle suspension versus dual-tracer-guided sentinel lymph node mapping in patients with early breast cancer: A prospective, randomized controlled, phase III clinical trial". Cancer Research 82, nr 4_Supplement (15.02.2022): P1–01–03—P1–01–03. http://dx.doi.org/10.1158/1538-7445.sabcs21-p1-01-03.
Pełny tekst źródłaLee, Eun Ji, Juwon Ahn, You Won Lee, Minyeop Kim, Seung Yeon Oh, Yong Joon Park, Su-Jin Choi i in. "Abstract 6868: Exploring myeloid landscapes according to EGFR mutated NSCLC tumor microenvironment". Cancer Research 84, nr 6_Supplement (22.03.2024): 6868. http://dx.doi.org/10.1158/1538-7445.am2024-6868.
Pełny tekst źródłaZhang, Jian, Dongmei Ji, Li Cai, Herui Yao, Min Yan, Xiaojia Wang, Weina Shen i in. "Abstract P2-13-10: First-in-human HER2-targeted bispecific antibody KN026 for the treatment of patients with HER2-positive metastatic breast cancer: Results from a phase I study". Cancer Research 82, nr 4_Supplement (15.02.2022): P2–13–10—P2–13–10. http://dx.doi.org/10.1158/1538-7445.sabcs21-p2-13-10.
Pełny tekst źródłaShin, Rumi, Byunho Jo, Inyeop Jang, Cheong-Il Shin, Jin Sun Choi, Seung-Yong Jeong, Seung Chul Heo, Ji Won Park, Min Jung Kim i Tae Hyun Hwang. "Abstract 5374: Why only focus on the tumor?: The crucial role of the extra-tumor environment to predict poor responders for locally advanced rectal cancer". Cancer Research 83, nr 7_Supplement (4.04.2023): 5374. http://dx.doi.org/10.1158/1538-7445.am2023-5374.
Pełny tekst źródłaYun, Dabin, Nan Song, Jin-Ah Sim, Min Jung Kim, Ji Won Park, Seung Yong Jeong i Aesun Shin. "Abstract 5234: Novel predictive biomarker SNPs and polygenic risk scores of immune-related genes for colorectal cancer survival in Korea". Cancer Research 83, nr 7_Supplement (4.04.2023): 5234. http://dx.doi.org/10.1158/1538-7445.am2023-5234.
Pełny tekst źródłaHoang, Tung, Min Jung Kim, Ji Won Park, Seung-Yong Jeong i Aesun Shin. "Abstract 2364: Gut microbiome interacts with clinical characteristics on all-cause mortality of colorectal cancer patients". Cancer Research 83, nr 7_Supplement (4.04.2023): 2364. http://dx.doi.org/10.1158/1538-7445.am2023-2364.
Pełny tekst źródłaKim, Jwa Hoon, Soohyeon Lee, Min Hee Hong, Jee Hyun Kim, Eun Joo Kang, Tae-Yong Kim, Yeon Hee Park i in. "Abstract 5209: Hyperprogression in various solid cancers treated with immune checkpoint inhibitors in the real world". Cancer Research 82, nr 12_Supplement (15.06.2022): 5209. http://dx.doi.org/10.1158/1538-7445.am2022-5209.
Pełny tekst źródłaPark, Minsu, Soeun Park, Juyeon Seo, Dongmi Ko, Seongjae Kim, Yong Koo Kang, Kee Dal Nam i in. "Abstract 6121: UCP2 inhibitor eradicates cancer stem-like population in trastuzumab-resistant HER2-positive breast cancer". Cancer Research 83, nr 7_Supplement (4.04.2023): 6121. http://dx.doi.org/10.1158/1538-7445.am2023-6121.
Pełny tekst źródłaPark, Hyeree, Tung Hoang, Min Jung Kim, Ji Won Park, Seung-Yong Jeong i Aesun Shin. "Abstract 5892: Microbial diversity and composition according to short-term postoperative complication status in colorectal cancer patients". Cancer Research 83, nr 7_Supplement (4.04.2023): 5892. http://dx.doi.org/10.1158/1538-7445.am2023-5892.
Pełny tekst źródłaPark, Hyeree, Min Jung Kim, Ji Won Park, Seung-Yong Jeong, Aesun Shin, Sung-Yup Cho, Eun Sung Jung, Dong Ho Suh, Sunyoung Lee i Yu Jin Park. "Abstract 2804: Comparative analysis of microbial diversity and abundance in colorectal cancer patients before and after surgery". Cancer Research 84, nr 6_Supplement (22.03.2024): 2804. http://dx.doi.org/10.1158/1538-7445.am2024-2804.
Pełny tekst źródłaCheng, Ying, Jie Wang, Caicun Zhou, Wenxiu Yao, Qiming Wang, Xuhong Min, Gongyan Chen i in. "Abstract CT038: Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage SCLC: A phase 3 trial". Cancer Research 82, nr 12_Supplement (15.06.2022): CT038. http://dx.doi.org/10.1158/1538-7445.am2022-ct038.
Pełny tekst źródłaPark, Su-Bin, Ji-Sik Kang, Min-Je Kim, Shin-Wha Lee, Dong-Woo Kang i Yong-Man Kim. "Abstract 6190: Anti-tumor effects of lenvatinib plus anti-PD-1 in syngeneic murine cervical cancer models". Cancer Research 82, nr 12_Supplement (15.06.2022): 6190. http://dx.doi.org/10.1158/1538-7445.am2022-6190.
Pełny tekst źródłaLee, Dae-Won, Sae-Won Han, Yoojoo Lim, Hwang-Phill Kim, Hanseong Roh, Min Jung Kim, Seung-Bum Ryoo i in. "Abstract 5157: ctDNA change predicts treatment outcome of regorafenib in metastatic colorectal cancer". Cancer Research 82, nr 12_Supplement (15.06.2022): 5157. http://dx.doi.org/10.1158/1538-7445.am2022-5157.
Pełny tekst źródłaRyu, Jai Min, Han-Byoel Lee, Sei Hyun Ahn, Il-Yong Chung, Seeyoun Lee, Seho Park, Woosung Lim i in. "Abstract PS01-03: What to expect from the No axillary surgical treatment for lymph node-negative patients after ultra-sonography [NAUTILUS] trial (KBCSG-21): Clinicopathologic characteristics and axillary lymph node status of enrolled patients". Cancer Research 84, nr 9_Supplement (2.05.2024): PS01–03—PS01–03. http://dx.doi.org/10.1158/1538-7445.sabcs23-ps01-03.
Pełny tekst źródła